Palomino Laboratories (PALX) Total Liabilities (2022 - 2025)

Palomino Laboratories recorded quarterly Total Liabilities of $336458.0 in Q4 2025, down 66.32% quarter-over-quarter from $999013.0 in Q3 2025, and up 115.08% year-over-year from $156431.0 in Q4 2024.

Palomino Laboratories' Total Liabilities history runs 4 years deep, the most recent figure standing at $336458.0 for Q4 2025.

  • In Q4 2025, Total Liabilities rose 115.08% year-over-year to $336458.0; the TTM figure through Dec 2025 stood at $336458.0 (up 115.08% YoY), while the FY2025 annual figure was $336458.0, up 115.08% from the prior year.
  • Total Liabilities came in at $336458.0 for Q4 2025 at Palomino Laboratories, down from $999013.0 in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $999013.0 in Q3 2025 to a low of $27804.0 in Q4 2022.
  • A 4-year average of $235268.4 and a median of $162925.0 in 2024 frame the typical range for Total Liabilities.
  • On a YoY basis, Total Liabilities climbed as much as 443.68% in 2024 and fell as far as 40.14% in 2024.
  • Palomino Laboratories' Total Liabilities stood at $27804.0 in 2022, then soared by 301.46% to $111621.0 in 2023, then jumped by 40.14% to $156431.0 in 2024, then surged by 115.08% to $336458.0 in 2025.
  • According to Business Quant data, Total Liabilities over the past three periods registered $336458.0, $999013.0, and $364431.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 336,458.00
Sep 30, 2025 999,013.00
Jun 30, 2025 364,431.00
Mar 31, 2025 336,989.00
Dec 31, 2024 156,431.00
Sep 30, 2024 221,754.00
Jun 30, 2024 194,658.00
Mar 31, 2024 162,925.00
Dec 31, 2023 111,621.00
Sep 30, 2023 79,047.00
Jun 30, 2023 35,804.00
Mar 31, 2023 31,554.00
Dec 31, 2022 27,804.00